Biogen Inc.BIIBNASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank57
3Y CAGR+0.2%
5Y CAGR-6.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+0.2%/yr
vs -3.4%/yr prior
5Y CAGR
-6.5%/yr
Recent acceleration
Acceleration
+3.6pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $5.04B | +3.3% |
| 2024 | $4.88B | -6.3% |
| 2023 | $5.20B | +4.0% |
| 2022 | $5.01B | -17.7% |
| 2021 | $6.08B | -13.7% |
| 2020 | $7.05B | +31.0% |
| 2019 | $5.38B | -6.4% |
| 2018 | $5.75B | +8.5% |
| 2017 | $5.30B | +8.9% |
| 2016 | $4.86B | - |